Daniel Bickford

Daniel Bickford has a wealth of experience in the healthcare industry, beginning with their role as Senior Market Manager at Ostex International, Inc. in 1997. Daniel then moved to NeoPath, Inc. in 1997, where they were the Director of Sales and Marketing, and was a key member of a team organized to change reimbursement levels at the Federal level. In 1998, they joined ESC Medical Systems Ltd. as the Director of Women's Health and ENT, where they managed the development and growth of the medical laser market. In 2000, they became the Executive Vice President of Sales and Marketing at NexCura Inc. and www.cancerfacts.com, leading business development, marketing, and sales efforts to close multiple cross-licensing agreements. In 2002, they co-founded Confirma, where they wrote the business plan, raised capital, launched product, hired staff, and managed all commercial activities. Daniel then moved to Merge Healthcare, an IBM Company in 2010, where they were the Vice President of Sales for the Western US. In 2011, they became the Director of Business Development at PenRad Technologies, Inc., responsible for all sales activities. In 2017, they joined Precision Image Analysis (PIA) as Director of Business Development, and was responsible for all commercial activities. Finally, in 2022, they became the Director of Business Development at Olea Medical - Improved Diagnosis for Life. In 2016, they also founded Pintail Strategic Advisors, LLC, a strategic business operations group specializing in startups with a focus on generating revenue and strategic partnerships.

Daniel Bickford completed a Bachelor of Applied Science (BASc) in Biochemistry and Molecular Biology from Western Washington University.